- Home
- AZI vs TLSA Comparison
AZI vs TLSA Comparison
Compare AZI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- TLSA
- Stock Information
- Founded
- AZI 2010
- TLSA 2013
- Country
- AZI China
- TLSA United Kingdom
- Employees
- AZI N/A
- TLSA N/A
- Industry
- AZI
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- TLSA Health Care
- Exchange
- AZI Nasdaq
- TLSA Nasdaq
- Market Cap
- AZI 23.8M
- TLSA 187.0M
- IPO Year
- AZI 2024
- TLSA 2000
- Fundamental
- Price
- AZI $0.41
- TLSA $1.45
- Analyst Decision
- AZI
- TLSA
- Analyst Count
- AZI 0
- TLSA 0
- Target Price
- AZI N/A
- TLSA N/A
- AVG Volume (30 Days)
- AZI 9.9M
- TLSA 246.7K
- Earning Date
- AZI 01-27-2025
- TLSA 07-22-2025
- Dividend Yield
- AZI N/A
- TLSA N/A
- EPS Growth
- AZI N/A
- TLSA N/A
- EPS
- AZI N/A
- TLSA N/A
- Revenue
- AZI $124,737,000.00
- TLSA N/A
- Revenue This Year
- AZI N/A
- TLSA N/A
- Revenue Next Year
- AZI N/A
- TLSA N/A
- P/E Ratio
- AZI N/A
- TLSA N/A
- Revenue Growth
- AZI 9.86
- TLSA N/A
- 52 Week Low
- AZI $0.19
- TLSA $0.63
- 52 Week High
- AZI $4.05
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- AZI N/A
- TLSA 48.43
- Support Level
- AZI N/A
- TLSA $1.43
- Resistance Level
- AZI N/A
- TLSA $1.81
- Average True Range (ATR)
- AZI 0.00
- TLSA 0.09
- MACD
- AZI 0.00
- TLSA -0.02
- Stochastic Oscillator
- AZI 0.00
- TLSA 18.53
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.